Compound class:
Synthetic organic
Comment: SRTCX1003 activates sirtuin 1 (SIRT1), an NAD+-dependent protein deacetylase [1].
|
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
SRTCX1003 increases SIRT1-mediated NF-κB deacetylation which leads to decreased production of proinflammatory cytokines (eg TNFα and IL-12), and may therefore have potential as a novel anti-inflammatory agent [1]. |